Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Fentanyl Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The fentanyl market has experienced significant expansion over recent years. Its projected growth will see it increase from $17.15 billion in 2025 to $18.17 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.9%. This historical progression can be linked to factors such as the increasing incidence of chronic and cancer-related pain, a rise in surgeries after operations, an expanding elderly demographic, widespread use of injectable opioids, and the development of hospital and clinical facilities.
The fentanyl market is anticipated to experience substantial expansion over the coming years, with its size projected to reach $23.8 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. This projected growth can be attributed to several factors, including the creation of new fentanyl formulations, the incorporation of AI into pain management strategies, a growing need for home-based palliative care services, an intensified focus on opioid safety and regulatory measures, and the expansion of ambulatory surgical centers. Key developments expected during this forecast period encompass personalized approaches to pain management, innovative transdermal drug delivery systems, less invasive anesthesia methods, opioid stewardship initiatives, and the advancement of new formulations.
Get A Free Sample Report With In-Depth Market Insights:
Fentanyl Market Growth Backed By Core Demand Fundamentals
The rising occurrence of chronic illnesses is anticipated to drive expansion in the fentanyl market in the future. A chronic ailment is defined as a health condition lasting an extended duration, typically at least three months, and frequently spanning an individual’s lifetime. Fentanyl finds its primary application in chronic conditions for addressing intense, ongoing pain when other treatments or therapies prove insufficient. For example, reports from October 2025 by the Australian Institute of Health and Welfare, an Australia-based government agency, indicated that during 2023, an estimated 57,100 adults aged 25 and above suffered acute coronary events, which translates to an average of roughly 156 incidents per day. Consequently, the expanding incidence of chronic diseases is propelling the growth of the fentanyl market.
Fentanyl Market Segment Breakdown: Which Categories Lead On Revenue?
The fentanyl market covered in this report is segmented –
1) By Type: Fentanyl Injections, Fentanyl TTS (Transdermal Therapeutic System)
2) By Application: Inducting Anesthesia, Maintain Anesthesia, General Analgesic, Postoperative Analgesia, Breakthrough Cancer Pain
3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Fentanyl Injections: Injectable Solutions, Premixed Injection Formulations
2) By Fentanyl TTS (Transdermal Therapeutic System): Patch Formulations, Matrix Patch Systems
Fentanyl Market Growth Trends Reshaping The Competitive Landscape
Leading companies in the fentanyl market are innovating with products like Opvee and securing regulatory approvals to expand their customer base, increase sales, and boost revenue. Opvee (nalmefene) acts as a potent opioid receptor blocker, effective in treating confirmed or suspected opioid overdoses caused by both natural and synthetic opioids, including fentanyl. For instance, in May 2023, Indivior PLC, a US-based pharmaceutical company, gained U.S. Food and Drug Administration approval for its Opvee nasal spray. This medication works by inhibiting the effects of opioids on the brain, which helps patients who have recently overdosed restore normal respiration and blood pressure. Delivered as a nasal spray, Opvee offers ease of administration during emergency situations. It is a vital component among the treatments used to combat opioid overdoses and save lives.
Fentanyl Market Leading Players And Competitive Positioning
Major companies operating in the fentanyl market are Pfizer Inc., Johnson & Johnson, Fresenius Kabi Oncology Ltd., Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Limited, Hisamitsu Pharmaceutical Co. Inc., Alvogen, Insys Therapeutics Inc., Paladin Labs Inc., Apotex Inc., Kyowa Kirin Co. Ltd., Luye Pharma Group, Henan Lingrui Pharmaceutical Ltd., Sinopharm Group, Jiangsu Nhwa Pharmaceutical Co. Ltd., Cephalon LLC, Validus Pharmaceuticals LLC, Quality Care Products LLC, Bryant Ranch Prepack Inc., Exela Pharma Sciences LLC
View The Full Fentanyl Market Report:
Fentanyl Market Largest Region By Revenue And Market Share
North America was the largest region in the fentanyl market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fentanyl market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
